MERZ on the Move: Days After Ulthera Acquisition, Company Announces Plans for New Retinoid Therapy
Days after Ulthera acquisition, company announces plans to develop new Retinoid Therapy with Brickell Biotech.
Days after Ulthera acquisition, company announces plans to develop new Retinoid Therapy with Brickell Biotech.
Older women undergoing breast reconstruction after mastectomy face slightly higher risks of complications but report better psychological well-being despite lower satisfaction with breast appearance, highlighting the need to weigh age-related risks and benefits when considering surgery.